Questionnaire Administration for Non-Small Cell Lung Cancer

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Non-Small Cell Lung Cancer+15 MoreQuestionnaire Administration - Other
Eligibility
Any Age
All Sexes
What conditions do you have?
Select

Study Summary

This trial is testing a decision aid to help patients with non-small cell lung cancer make better decisions about their care. The goal is to improve patient involvement, satisfaction, and communication with their physician.

Eligible Conditions
  • Non-Small Cell Lung Cancer
  • Stage IIB Lung Cancer
  • Stage IIIB Lung Cancer
  • Stage III Lung Cancer
  • Stage IVB Lung Cancer
  • Stage IA2 Lung Cancer
  • Stage IVA Lung Cancer
  • Stage IA1 Lung Cancer
  • Stage IIIA Lung Cancer
  • Stage IV Lung Cancer
  • Stage IB Lung Cancer
  • Stage II Lung Cancer
  • Stage I Lung Cancer
  • Stage IA3 Lung Cancer
  • Stage IIA Lung Cancer

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

2 Primary · 8 Secondary · Reporting Duration: From enrollment to the end of follow-up at 8 weeks

At enrollment
Acceptability of the conversation tool
Feasibility of the conversation tool
Week 8
Decisional Regret
Decisional conflict
Perceived involvement in care
Shared decision-making quality
Week 8
Anxiety
Decision making involvement
Self-efficacy
Values-treatment concordance

Trial Safety

Trial Design

2 Treatment Groups

Arm II (usual care)
1 of 2
Arm I (conversation tool)
1 of 2

Active Control

Experimental Treatment

100 Total Participants · 2 Treatment Groups

Primary Treatment: Questionnaire Administration · No Placebo Group · N/A

Arm I (conversation tool)Experimental Group · 2 Interventions: Questionnaire Administration, Informational Intervention · Intervention Types: Other, Other
Arm II (usual care)ActiveComparator Group · 2 Interventions: Questionnaire Administration, Best Practice · Intervention Types: Other, Other

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: from enrollment to the end of follow-up at 8 weeks

Who is running the clinical trial?

OHSU Knight Cancer InstituteLead Sponsor
208 Previous Clinical Trials
2,089,335 Total Patients Enrolled
Oregon Health and Science UniversityOTHER
893 Previous Clinical Trials
6,829,274 Total Patients Enrolled
Donald SullivanPrincipal Investigator - OHSU Knight Cancer Institute
OHSU Knight Cancer Institute

Eligibility Criteria

Age Any Age · All Participants · 6 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You must be able to speak and write English fluently.
You are fluent in English.
You have a life expectancy of at least 6 months.
You have completed treatment for suspected or confirmed stage I-IV non-small cell lung cancer (NSCLC).
You have undergone diagnostic work-up for suspected stage I-IV NSCLC.